Multifunctional platform for future applications in cell and tissue engineering based on silicate phosphate hydroxyapatite co-doped with Li

Sammanfattning

Although hydroxyapatite has established itself as a promising biomaterial for the simultaneous diagnosis and treatment of bone defects, several physicochemical properties can be further refined to achieve a specialized theranostic platform for cell and tissue engineering. In this context, we synthesized silicate-substituted hydroxyapatites co-doped with Li + , Eu 3 + , and Gd 3 + ions (abbr. as Si-HAp-LEG) using a microwave-assisted hydrothermal method. The aim was to create a combination of dopants to stimulate bone regeneration (Li + ion) while enabling bioimaging (Eu 3 + and Gd 3 + ions). Structural and morphological assessments included, e.g., XRPD (X-ray Powder Diffraction), HR-TEM (High -resolution Transmission Electron Microscopy) imaging, and BET (Brauner-Emmet-Teller) analysis. Unit-cell parameters were estimated via Rietveld refinement. The luminescence properties (emission, excitation spectra, and emission kinetics) were recorded depending on the varying Li + -ion concentration. The cytocompatibility of biomaterials was tested using hBMSCs (multipotent human bonemarrow mesenchymal stromal cells). In vitro assays evaluated biomaterials ' effects on morphology, metabolic activity (Alamar blue assay), and transcriptomic activity (RT-qPCR). The results indicate that co-doping with Li + , Eu 3 + , and Gd 3 + ions introduces distortions while preserving the crystal structure of hydroxyapatite. Additionally, the cells maintained proper morphology and ultrastructure, internalizing biomaterials without significant cytotoxicity. The biomaterials also triggered the expression of key transcriptional factors. Si-HAp-LEG biomaterials, particularly LEG -222 and LEG -221, exhibit desired physicochemical and biological features, rendering them highly bioactive and promising for cell and tissue engineering applications.

Nyckelord

Silicate-substituted hydroxyapatite; Rare earth ions; Theranostic platform; Tissue engineering; Theranostic applications

Publicerad i

Materials Today Communications
2024, Volym: 39, artikelnummer: 108926Utgivare: ELSEVIER

SLU författare

• Targonska, Sara

  • Institutionen för molekylära vetenskaper, Sveriges lantbruksuniversitet
    

UKÄ forskningsämne

Biomaterialvetenskap


Publikationens identifierare

DOI: https://doi.org/10.1016/j.mtcomm.2024.108926

Permanent länk till denna sida (URI)

https://res.slu.se/id/publ/130820